These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 6166142)

  • 21. Demonstration of human breast carcinoma cells in cryosections and primary monolayer cultures of surgical biopsies by neotetrazolium reductase cytochemistry.
    Petersen OW; van Deurs B
    Cancer Res; 1986 Apr; 46(4 Pt 2):2013-20. PubMed ID: 3081261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mammary lesions diagnosed as "papillary" by aspiration biopsy: 70 cases with follow-up.
    Simsir A; Waisman J; Thorner K; Cangiarella J
    Cancer; 2003 Jun; 99(3):156-65. PubMed ID: 12811856
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heterogeneous immunoreactivity of frozen human benign and malignant breast lesions to C-MYC and C-Ha-ras cellular oncogenes.
    Pechoux C; Chardonnet Y; Chignol MC; Noël P
    Histol Histopathol; 1994 Jan; 9(1):35-44. PubMed ID: 8003818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Accuracy of cytologic diagnoses made from touch imprints of image-guided needle biopsy specimens of nonpalpable breast abnormalities.
    Sneige N; Tulbah A
    Diagn Cytopathol; 2000 Jul; 23(1):29-34. PubMed ID: 10907929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cytopathology of the breast--benign and malignant neoplastic conditions].
    Moriki T; Takahashi T; Ueda S; Wada M; Ichien M; Hashimoto M
    Rinsho Byori; 1999 Jul; 47(7):585-92. PubMed ID: 10442036
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Benign lesions of the breast].
    Pettinato G; Panico L; de Rosa N; D'Antonio A; Bifano D; Avallone M
    Ann Ital Chir; 1997; 68(2):151-66. PubMed ID: 9290005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of nipple discharge cytology in the diagnosis of breast disease: a study of 1948 nipple discharge smears from 1530 patients.
    Gupta RK; Gaskell D; Dowle CS; Simpson JS; King BR; Naran S; Lallu S; Fauck R
    Cytopathology; 2004 Dec; 15(6):326-30. PubMed ID: 15606366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of frozen sections in grossly benign breast biopsies.
    Speights VO
    Mod Pathol; 1994 Sep; 7(7):762-5. PubMed ID: 7824510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intraoperative evaluation of axillary sentinel lymph nodes using touch imprint cytology and immunohistochemistry. Part II. Results.
    Salem AA; Douglas-Jones AG; Sweetland HM; Mansel RE
    Eur J Surg Oncol; 2006 Jun; 32(5):484-7. PubMed ID: 16569493
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nucleolar organizer regions distribution in fine needle aspiration cytological smears from breast lesions.
    Hasnan J; Jayaram G
    Malays J Pathol; 1996 Jun; 18(1):35-41. PubMed ID: 10879223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A correlation of breast imprints (stained by the method of Papanicolaou) and tissue sections.
    Pilar PB; Rubenstone AI
    Acta Cytol; 1968; 12(6):462-72. PubMed ID: 4177444
    [No Abstract]   [Full Text] [Related]  

  • 33. Argyrophilic nucleolar organiser regions (AgNORs) in breast lesions.
    Dasgupta A; Ghosh RN; Sarkar R; Laha RN; Ghosh TK; Mukherjee C
    J Indian Med Assoc; 1997 Sep; 95(9):492-4. PubMed ID: 9529579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The "gray zone" in fine needle aspiration cytology of the breast].
    Bak M; Szabó E; Mándoky L
    Magy Seb; 2005 Feb; 58(1):3-7. PubMed ID: 16018594
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictive power of cytomorphological features in equivocal (C3, C4) breast FNAC.
    Moyes C; Dunne B
    Cytopathology; 2004 Dec; 15(6):305-10. PubMed ID: 15606362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effort, accuracy and histology of MR-guided vacuum biopsy of suspicious breast lesions--retrospective evaluation after 389 interventions].
    Fischer U; Schwethelm L; Baum FT; Luftner-Nagel S; Teubner J
    Rofo; 2009 Aug; 181(8):774-81. PubMed ID: 19582655
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Touch imprint cytology of core needle biopsy specimens: a useful method for immediate reporting of symptomatic breast lesions.
    Klevesath MB; Godwin RJ; Bannon R; Munthali L; Coveney E
    Eur J Surg Oncol; 2005 Jun; 31(5):490-4. PubMed ID: 15922884
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Malignant breast lesions that may mimic benign tumors.
    Weidner N
    Semin Diagn Pathol; 1995 Feb; 12(1):2-13. PubMed ID: 7770672
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of c-myc, erbB-2, p53 and nm23-H1 gene product in benign and malignant breast lesions: coexpression and correlation with clinicopathologic parameters.
    Sirotkovic-Skerlev M; Krizanac S; Kapitanovic S; Husnjak K; Unusic J; Pavelic K
    Exp Mol Pathol; 2005 Aug; 79(1):42-50. PubMed ID: 16005711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of immunocytochemical markers in the differential diagnosis of proliferative and neoplastic lesions of the breast.
    Joshi MG; Lee AK; Pedersen CA; Schnitt S; Camus MG; Hughes KS
    Mod Pathol; 1996 Jan; 9(1):57-62. PubMed ID: 8821958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.